These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33350036)

  • 1. A novel rapid immunoassay of serum type IV collagen 7S for the diagnosis of fibrosis stage of nonalcoholic fatty liver diseases.
    Shima T; Ohtakaki Y; Kikuchi H; Uchino H; Isomura M; Aoyagi K; Oya H; Katayama T; Mitsumoto Y; Mizuno M; Umemura A; Yamaguchi K; Itoh Y; Okanoue T
    Hepatol Res; 2021 Mar; 51(3):263-276. PubMed ID: 33350036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease.
    Honda Y; Yoneda M; Kobayashi T; Iwaki M; Kawamura N; Nogami A; Kessoku T; Ogawa Y; Tomeno W; Imajo K; Horita N; Saito S; Kaneko T; Nakajima A
    Hepatol Res; 2023 Mar; 53(3):219-227. PubMed ID: 36378589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa, Japan.
    Honma KI; Nakayama Y; Tamaki A; Uehara M; Teruya T; Yabiku T; Ishiki Y; Yonaha K; Chinen R; Uema T; Okamoto S; Masuzaki H
    Endocr J; 2024 Jun; ():. PubMed ID: 38910122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a New Chemiluminescent Enzyme Immunoassay Using a Two-Step Sandwich Method for Measuring Aldosterone Concentrations.
    Ozeki Y; Tanimura Y; Nagai S; Nomura T; Kinoshita M; Shibuta K; Matsuda N; Miyamoto S; Yoshida Y; Okamoto M; Gotoh K; Masaki T; Kambara K; Shibata H
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33806394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison and commutability study between standardized liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood.
    Nishikawa T; Satoh F; Takashi Y; Yanase T; Itoh H; Kurihara I; Shibata H; Oki Y; Naruse M; Sasamoto H; Kuwa K
    Endocr J; 2022 Jan; 69(1):45-54. PubMed ID: 34305069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.
    Ogawa Y; Honda Y; Kessoku T; Tomeno W; Imajo K; Yoneda M; Kawanaka M; Kirikoshi H; Ono M; Taguri M; Saito S; Yamanaka T; Wada K; Nakajima A
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1795-1803. PubMed ID: 29633352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of patients with non-alcoholic fatty liver disease using rapid immunoassay of serum type IV collagen compared with liver histology and other fibrosis markers.
    Mizuno M; Shima T; Oya H; Mitsumoto Y; Mizuno C; Isoda S; Kuramoto M; Taniguchi M; Noda M; Sakai K; Koyama N; Okanoue T
    Hepatol Res; 2017 Feb; 47(2):216-225. PubMed ID: 26997642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-Assessment of the Oral Salt Loading Test Using a New Chemiluminescent Enzyme Immunoassay Based on a Two-Step Sandwich Method to Measure 24-Hour Urine Aldosterone Excretion.
    Ozeki Y; Kinoshita M; Miyamoto S; Yoshida Y; Okamoto M; Gotoh K; Masaki T; Kambara K; Shibata H
    Front Endocrinol (Lausanne); 2022; 13():859347. PubMed ID: 35388294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease.
    Murawaki Y; Ikuta Y; Koda M; Yamada S; Kawasaki H
    J Hepatol; 1996 Feb; 24(2):148-54. PubMed ID: 8907567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease.
    Masugi Y; Abe T; Tsujikawa H; Effendi K; Hashiguchi A; Abe M; Imai Y; Hino K; Hige S; Kawanaka M; Yamada G; Kage M; Korenaga M; Hiasa Y; Mizokami M; Sakamoto M
    Hepatol Commun; 2018 Jan; 2(1):58-68. PubMed ID: 29404513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of monoclonal antibodies against a soluble form of lectin-like oxidized low-density lipoprotein receptor-1 and development of a sensitive chemiluminescent enzyme immunoassay.
    Nakamura M; Ohta H; Kume N; Hayashida K; Tanaka M; Mitsuoka H; Kaneshige T; Misaki S; Imagawa K; Shimosako K; Ogawa N; Kita T; Kominami G
    J Pharm Biomed Anal; 2010 Jan; 51(1):158-63. PubMed ID: 19632802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis.
    Okanoue T; Ebise H; Kai T; Mizuno M; Shima T; Ichihara J; Aoki M
    J Gastroenterol; 2018 Jan; 53(1):129-139. PubMed ID: 28589339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography.
    Yoneda M; Suzuki K; Kato S; Fujita K; Nozaki Y; Hosono K; Saito S; Nakajima A
    Radiology; 2010 Aug; 256(2):640-7. PubMed ID: 20529989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advent of innovative chemiluminescent enzyme immunoassay.
    Lee JH; Rho JE; Rho TH; Newby JG
    Biosens Bioelectron; 2010 Oct; 26(2):377-82. PubMed ID: 20739174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis.
    Hirose O; Itabashi M; Takei T; Nitta K
    Mod Rheumatol; 2015 Mar; 25(2):230-4. PubMed ID: 25388618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements in international units of antibody to hepatitis B surface antigen(anti-HBs) after immunization with a yeast-derived, subtype adr hepatitis B vaccine are considerably different between chemiluminescent immunoassay (CLIA) and chemiluminescent enzyme immunoassay (CLEIA).
    Ogata N
    Rinsho Byori; 2006 Apr; 54(4):340-3. PubMed ID: 16722452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and sensitive chemiluminescent enzyme immunoassay for measuring tumor markers.
    Nishizono I; Iida S; Suzuki N; Kawada H; Murakami H; Ashihara Y; Okada M
    Clin Chem; 1991 Sep; 37(9):1639-44. PubMed ID: 1716538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.